Cargando…
Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
Background: PD-L1 has been widely reported as immune check points in a range of malignancies as well as some immune-originated diseases. In glioma, the role of PD-L1 remains unclear. We aimed at investigating its role at transcriptome level and relationship with clinical practice. Method and patient...
Autores principales: | Wang, Zheng, Zhang, Chuanbao, Liu, Xing, Wang, Zhiliang, Sun, Lihua, Li, Guanzhang, Liang, Jingshan, Hu, Huimin, Liu, Yanwei, Zhang, Wei, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139638/ https://www.ncbi.nlm.nih.gov/pubmed/27999734 http://dx.doi.org/10.1080/2162402X.2016.1196310 |
Ejemplares similares
-
Genetic and clinical characterization of B7‐H3 (CD276) expression and epigenetic regulation in diffuse brain glioma
por: Wang, Zhiliang, et al.
Publicado: (2018) -
MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status
por: Li, Guanzhang, et al.
Publicado: (2018) -
FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients
por: Wang, Zheng, et al.
Publicado: (2016) -
Comparative profiling of immune genes improves the prognoses of lower grade gliomas
por: Wang, Zhiliang, et al.
Publicado: (2022) -
Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018)